Synonyms: compound 13e [PMID: 22512618] | TAK-438 | TAK438 | Takecab® | TAKECAB® | Vocinti® | Voquezna®
vonoprazan is an approved drug (Japan (2014), FDA (2022))
Compound class:
Synthetic organic
Comment: Vonoprazan (TAK-438) is a first-in-class, potassium competitive acid blocker (P-CAB) class agent [4,7]. It reduces gastric acid production via reversible inhibition of the gastric proton pump ATPase (a.k.a. gastric H+,K+-ATPase) [1-2,7]. The compound appears to dock within the luminal vestibule of the proton pump's alpha subunit (ATP4A) and prevents K+ access to the ion binding domain, with a Ki of 3 nM for the wild type H+,K+-ATPase [7]. Vonoprazan has a faster onset of action than widely used proton pump inhibitors (PPI), doesn't require acid-mediated activation and provides long-lasting inhibition (due to its slow dissociation rate) of the gastric H+,K+-ATPase [5-6].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes. Japan (2014) | FDA (2022) |
IUPAC Name ![]() |
1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-N-methylmethanamine |
International Nonproprietary Names ![]() |
|
INN number | INN |
9535 | vonoprazan |
Synonyms ![]() |
compound 13e [PMID: 22512618] | TAK-438 | TAK438 | Takecab® | TAKECAB® | Vocinti® | Voquezna® |
Database Links ![]() |
|
ChEMBL Ligand | CHEMBL2079130 |
DrugBank Ligand | DB11739 |
GtoPdb PubChem SID | 441604921 |
PubChem CID | 15981397 |
RCSB PDB Ligand | HKT |
Search Google for chemical match using the InChIKey | BFDBKMOZYNOTPK-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | BFDBKMOZYNOTPK |
Search PubMed clinical trials | vonoprazan |
Search PubMed titles | vonoprazan |
Search PubMed titles/abstracts | vonoprazan |
UniChem Compound Search for chemical match using the InChIKey | BFDBKMOZYNOTPK-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | BFDBKMOZYNOTPK-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Vonoprazan (links to external site)
Cat. No. HY-100007 |